← European Medicine Shortage Tracker · all medicines

Duloxetina cloridrato shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Duloxetina cloridrato currently has availability issues reported in 1 European register: Italy.

Shortage  ATC — · also listed as: DULOXETINA CLORIDRATO · data refreshed 9 September 2026

Key facts

As of 9 September 2026, 1 of the 9 tracked registers list current availability issues for Duloxetina cloridrato, covering 13 affected product presentations. The longest-running open report was filed in Italy on 2024-09-30 and has now been open for about 24 months. Where agencies state a cause, manufacturing problems lead with 9 of the 13 stated-cause reports, followed by commercial decisions or discontinuation with 4. The furthest expected-resolution date currently on file is 2026-12-31; the earliest is 2026-12-31. Momentum is current, not historical: 3 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
ALIKRES
+ 12 more products
ALIKRES
DULEX
DULEX
DULEX
DULOXETINA ALMUS
DULOXETINA EG
DULOXETINA VIATRIS
DULOXETINA VIATRIS
DULOXETINA VIATRIS
DULOXETINA ZENTIVA
YENTREVE
YENTREVE
2024-09-302026-12-31Cessata commercializzazione definitiva
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

New register reports per month

2024-09: 12024-10: 02024-11: 12024-12: 02025-01: 12025-02: 02025-03: 02025-04: 02025-05: 02025-06: 02025-07: 02025-08: 12025-09: 12025-10: 12025-11: 12025-12: 02026-01: 12026-02: 02026-03: 12026-04: 12026-05: 02026-06: 02026-07: 02026-08: 12026-09: 12024-092026-09

Full report history (13 register entries)

Every individual register entry for Duloxetina cloridrato in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITALIKRESShortage2027-01-31Cessata commercializzazione definitiva
🇮🇹 ITALIKRESShortage2026-09-30Cessata commercializzazione definitiva
🇮🇹 ITDULEXShortage2026-08-31Problemi produttivi
🇮🇹 ITDULEXShortage2026-04-13Problemi produttivi
🇮🇹 ITDULOXETINA VIATRISShortage2026-03-01Problemi produttivi
🇮🇹 ITDULEXShortage2026-01-07Problemi produttivi
🇮🇹 ITDULOXETINA ALMUSShortage2025-11-172026-12-31Problemi produttivi
🇮🇹 ITDULOXETINA EGShortage2025-10-31Problemi produttivi
🇮🇹 ITYENTREVEShortage2025-09-30Cessata commercializzazione definitiva
🇮🇹 ITYENTREVEShortage2025-08-30Cessata commercializzazione definitiva
🇮🇹 ITDULOXETINA VIATRISShortage2025-01-01Elevata richiesta/problemi produttivi
🇮🇹 ITDULOXETINA VIATRISShortage2024-11-01Elevata richiesta/problemi produttivi
🇮🇹 ITDULOXETINA ZENTIVAShortage2024-09-30Problemi produttivi: forniture discontinue

Frequently asked

Is Duloxetina cloridrato currently in shortage in Europe?

Yes. As of 9 September 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Duloxetina cloridrato shortage expected to end?

Agency prognoses on file range from 2026-12-31 to 2026-12-31. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Duloxetina cloridrato?

13 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Duloxetina cloridrato availability data come from?

Directly from the official medicines-agency register that lists Duloxetina cloridrato: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Duloxetina cloridrato — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/duloxetina-cloridrato/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Duloxetina cloridrato availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/duloxetina-cloridrato/">Duloxetina cloridrato shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Duloxetina cloridrato: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 9 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.